Experience

LynxDx

• United States
• Biotechnology Research
• 1 - 100 Employee

• Clinical Laboratory Technician

  • Jul 2020 - Present

  Ann Arbor, Michigan, United States

• Laboratory Technician

  • Jun 2020 - Present



John D Dingell Vamc

• United States
• Armed Forces
• 100 - 200 Employee

• Research Assistant

  • Jul 2019 - Jul 2020

  Greater Detroit Area



Karmanos Cancer Institute

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Assistant

  • Jun 2008 - Jun 2019

  Greater Detroit Area RESEARCH 1) Tumors escape immune surveillance by creating an abnormal state of tolerance towards their own antigens, thus escaping the body’s immune response; I have been examining IDO and the Kynurenine pathway and its effects on the growth and survival gliomas, meningiomas and metastatic brain tumors. 2) Study the distribution and the of effects of activated microglia, the central nervous system’s resident macrophage cells, inside the glioblastoma multiforme (GBM) tumor versus the… Show more RESEARCH 1) Tumors escape immune surveillance by creating an abnormal state of tolerance towards their own antigens, thus escaping the body’s immune response; I have been examining IDO and the Kynurenine pathway and its effects on the growth and survival gliomas, meningiomas and metastatic brain tumors. 2) Study the distribution and the of effects of activated microglia, the central nervous system’s resident macrophage cells, inside the glioblastoma multiforme (GBM) tumor versus the infiltrating edge, and its effects on the tumor and microenvironment in terms of anti and pro inflammation and tumorigenesis properties. Also study the effect of osteopontin (OPN), overexpressed in a variety of cancers, and its role in tumorigenesis, inflammation, metastasis, and immune response. 3) Current projects in the lab involve metabolic reprogramming of glycolysis in GBM (both cell lines and primary neurosphere cultures) using simultaneous inhibition of dual metabolic pathways. We focus on lactate efflux using candidate small molecule inhibitors with concomitant targeting of mitochondrial dehydrogenase pathways. Both metabolomics and pharmacological studies are conducted to monitor and verify synergistic effects of our metabolic targeting strategies. RECENT PUBLICATIONS 1) pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma (2017). Caruso JP, Koch BJ, Benson PD, Varughese E, Monterey MD, Lee AE, Dave AM, Kiousis S, Sloan AE, Mathupala SP. Neoplasia. 2017 Jan 13;19(2):121-134. doi: 10.1016/j.neo.2016.12.011. 2) A Lab Assembled Microcontroller-Based Sensor Module for Continuous Oxygen Measurement in Portable Hypoxia Chambers (2016). Mathupala SP, Kiousis S, and Szerlip NJ. PLoS One. 2016 Feb 10;11(2):e0148923. doi: 10.1371/journal.pone.0148923. Show less